A story in the Jan. 25, 2005, issue of BioWorld Today should have said GTC Biotherapeutics Inc. raised $10.4 million through a sale of 7.7 million common shares at $1.35 apiece.

Editor's Note: The correction has been made in BioWorld Online.

No Comments